Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley
et al (show 7 more authors) (2023) The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24 (2). 1746-.


Banna, Giuseppe L, Cantale, Ornella, Muthuramalingam, Sethupathi, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Signori, Alessio, McKenzie, Hayley, Escriu, Carles ORCID: 0000-0003-3638-3202
et al (show 7 more authors) (2022) Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study. INTERNATIONAL IMMUNOPHARMACOLOGY, 110. 108985-.


Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley
et al (show 9 more authors) (2023) Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis. FRONTIERS IN ONCOLOGY, 13. 1163768-.


Middleton, Gary, Brock, Kristian, Savage, Joshua, Mant, Rhys, Summers, Yvonne, Connibear, John, Shah, Riyaz, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Shaw, Paul, Lee, Siow-Ming
et al (show 4 more authors) (2020) Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial. The Lancet Respiratory Medicine, 8 (9). pp. 895-904.

This list was generated on Mon Jan 8 01:40:52 2024 GMT.